Okamoto M, Ueda Y, Takahashi K, Nakazawa H, Doi T
Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., Osaka, Japan.
Biosci Biotechnol Biochem. 1995 Sep;59(9):1740-1. doi: 10.1271/bbb.59.1740.
The enantiomeric separation of SM-10661, a platelet activating factor receptor antagonist, was investigated by HPLC using ligand-exchange chiral stationary phases. The stereoisomers of SM-10661 could all be separated by ligand-exchange HPLC with a Cu(II) N,S-dioctyl-D-penicillamine complex (Sumichiral OA-5000). The mechanism for the resolution includes the involvement of hydrophobic interactions between SM-10661 and Cu(II) D-penicillamine.